New 5-session radiation plan aims to ease spine tumor pain with fewer side effects
NCT ID NCT04802603
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new way to deliver radiation to spine tumors that have spread from other cancers. Instead of the usual 1-2 high-dose sessions, the radiation is given in 5 smaller doses over several days, which may reduce side effects. The trial will enroll 60 adults with spine metastases and measure pain relief, quality of life, and how well the treatment is tolerated.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Spine stereotactic body radiotherapy (radiation)
What this could lead to
If successful, this could offer a safer, more tolerable radiation option for people with spine tumors that have spread from other cancers, potentially reducing pain and improving daily function.
What could go wrong
This is a small, early-phase study with only 60 participants, so results may not apply to everyone. Radiation still carries risks like nerve damage or fatigue, and the approach may not work better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Miami Cancer Institute at Baptist Health, Inc
RECRUITINGMiami, Florida, 33176, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact